REGISTER now: Visser ai webinar - BEYOND THE HYPE: AI IN PATENT PROSECUTION
​

'Gene Patents in Europe Relatively Stable Despite Uncertainty in the US', by Andrew Sharples

No items found.
​
25 March 2011
Tags
Life
Table of contents
  • Toc Heading
  • Toc Heading

Partner and head of EIP Life, Andrew Sharples, has had an article published on the website of a US biotech magazine, Genetic Engineering and Biotechnology News (GEN).

The article entitled Gene Patents in Europe Relatively Stable Despite Uncertainty in the US, discusses the future of gene patents in Europe contrasting the European position with the US Myriad case.

To read the article in full, click here.

Related articles

See all articles

EIP strengthens Swedish presence with dedicated Malmö office
10 November 2026
EIP has strengthened its presence in Sweden with a dedicated Malmö office, reflecting the continued growth of our team in southern Sweden. The Malmö team supports innovative businesses with intellectual property expertise, helping them protect their ideas and maximise their commercial value.
​
EIP named in The Times Best Law Firms for a second year running
05 November 2026
EIP have been named in The Times Best Law Firms 2027 and commended for intellectual property, for the second consecutive year.
​
EIP ranked Band 1 in Chambers UK 2027, with three lawyers also recognised
14 October 2026
Chambers recognised EIP for its patent litigation work and its strength in disputes concerning FRAND licensing and standard essential patents.
​